Organon & Co - Company Profile
Powered by
All the data and insights you need on Organon & Co in one report.
- Save hours of research time and resources with
our up-to-date Organon & Co Strategy Report
- Understand Organon & Co position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Organon & Co (Organon) is a healthcare company that focuses on the discovery, development, and commercialization of biosimilars and drugs for various disease conditions including respiratory, cardiovascular, dermatology, non-opioid pain, women’s health and others. Marketing and distribution capabilities, established brands, and focus on R&D are the major strengths of the company, even as decline in financial performance is a cause for concern. However, the company could benefit from strategic initiatives, growing incidence of cancer and increasing incidence of cardiovascular diseases. Nevertheless, its performance could be affected by competitive environment, dependence on third parties and stringent government regulations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer